COMP <GO>
ZKIN vs TMO // EV/EBITDA & P/E VALUATION
ZK International Group Co. Ltd Ordinary Share (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: ZKIN 0
— TMO 8
■ METRIC PARITY
LAST: $1.40 (-7.28%) • MKT CAP: $80.2M
valuation
—
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
valuation
30.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ZKIN VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ZKIN | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 5.70% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | 9.30% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 30.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 0.18% | 2.40% | -2.22 | TMO | /fcf-yield <GO> |
| Operating Margin | -6.00% | 17.40% | -23.40 | TMO | /operating-margins <GO> |
| Net Profit Margin | -5.60% | 15.10% | -20.70 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | -34.20% | 3.90% | -38.10 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 4.50 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 8/9 | -5.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 42.1 | 62.9 | -20.75 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 36.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $80.2M | $262.22B | -$262.14B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ZKIN REV | TMO REV | ZKIN GROSS % | TMO GROSS % | ZKIN FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $71.2M | $44.56B | 5.7% | — | $147.8K | $6.29B |
| FY 2024 | $108.2M | $42.88B | 6.1% | — | -$7.5M | $7.27B |
| FY 2023 | $111.6M | $42.86B | — | — | -$1.9M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ZKIN // BETA —
TMO // BETA 0.94